Biotech News

Nov. 9 -- Pfizer Inc. has paid some of the largest fines in the industry after promising to stop marketing drugs for off-label uses in 2004.

BRITISH pharmaceutical giant GlaxoSmithKline said on Tuesday it will donate 50 million doses of its H1N1 flu vaccine to the World Health Organisation to distribute to developing countries.

Bristol-Myers Squibb Co. and Alder Biopharmaceuticals Inc. said Tuesday they signed a collaboration deal potentially worth $1 billion, with a key focus on a rheumatoid arthritis treatment.

The Food and Drug Administration needs three more months to review an application to a neuropathic pain drug being developed by XenoPort Inc.

Vancouver - Published on Monday, Nov. 09, 2009 8:59AM EST Last updated on Monday, Nov.

Enzon Pharmaceuticals, Inc. announced Monday that it intends to sell its specialty pharmaceutical business to the sigma-tau Group for more than $300 million.

Nov. 9 -- Robert Glassman, private equity partner at OrbiMed Advisors, talks with Bloomberg's Erik Schatzker and Deirdre Bolton about the practice of so-called off-label drug marketing and its impact on the industry.

Pfizer trimming research plants after buying Wyeth NEW YORK - The world's biggest drugmaker is closing six of its 20 research facilities, reorganizing others, and cutting the jobs of roughly 15 percent of its scientists and support staff.

Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX Compared With Placebo Main Category: Smoking / Quit Smoking Also Included In: Respiratory / Asthma ; COPD Article Date: 05 Nov 2009 - 13:00 PST New study results showed that 42.3 percent of smokers with mild-to-moderate chronic obstructive pulmonary disease ...

Antigenics, Inc. today indicated that GlaxoSmithKline's Phase III malaria vaccine clinical trial, containing Antigenics' QS-21 Stimulon adjuvant, has enrolled more than 5,000 children to date and is expected to involve up to 16,000 children.

Required fields are marked with an asterisk The information you provide will be used only to send the requested e-mail and will not be used to send any other e-mail communications.

ZIOPHARM Oncology, Inc. presented today at the 15th Annual Connective Tissue Oncology Society Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide treating patients with unresectable or metastatic soft tissue sarcoma.

Main Category: Lung Cancer Also Included In: Clinical Trials / Drug Trials ; Conferences ; Pharma Industry / Biotech Industry Article Date: 07 Nov 2009 - 1:00 PST Oncolytics Biotech Inc.

Bristol-Myers Squibb Company today announced that the FDA has approved a labeling update for REYATAZ A to include long-term data from the CASTLE Study.

Wall Street insider trading probe widens An unidentified suspect charged with fraud and conspiracy in the Galleon Group insider trading scandal arrives at Manhattan Federal Court in FBI custody on Thursday.

Biotechnology company Incyte Corp. said Thursday its third-quarter loss narrowed on lower costs as it prioritized is pipeline of potential products.

The productivity of U.S. workers surged in the third quarter at the fastest pace in six years as companies squeezed more from remaining staff to boost profits.

To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the official grand opening of its expanded regional headquarters facility in Singapore's Science Park I.

Only about a third of adults who have tried to get a swine flu vaccine have been able to get it, according to a new national poll released Friday.

PURCHASE,A N.Y. Nutrition 21 on Friday announced that the company has obtained an exclusive license for a patented combination of a probiotic and omega-3 fish oil from ProbioHealth and ProbioFerm.